
### [MONDO:0019852](http://purl.obolibrary.org/obo/MONDO_0019852)
**Label:** non-acquired premature ovarian failure

**Subclasses:** [MONDO:0017312](http://purl.obolibrary.org/obo/MONDO_0017312) (Perrault syndrome), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0007201](http://purl.obolibrary.org/obo/MONDO_0007201) (blepharophimosis, ptosis, and epicanthus inversus syndrome), [MONDO:0009299](http://purl.obolibrary.org/obo/MONDO_0009299) (46 XX gonadal dysgenesis), [MONDO:0019499](http://purl.obolibrary.org/obo/MONDO_0019499) (Turner syndrome), [MONDO:0018575](http://purl.obolibrary.org/obo/MONDO_0018575) (microcephalic primordial dwarfism-insulin resistance syndrome), [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0008725](http://purl.obolibrary.org/obo/MONDO_0008725) (congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0010766](http://purl.obolibrary.org/obo/MONDO_0010766) (46,XX testicular disorder of sex development), 

**Corr. equiv. classes:** [Orphanet:881](http://www.orpha.net/ORDO/Orphanet_881), [Orphanet:100](http://www.orpha.net/ORDO/Orphanet_100), [Orphanet:243](http://www.orpha.net/ORDO/Orphanet_243), [OMIM:110100](http://purl.obolibrary.org/obo/OMIM_110100), [OMIM:201710](http://purl.obolibrary.org/obo/OMIM_201710), [Orphanet:393](http://www.orpha.net/ORDO/Orphanet_393), [OMIM:202110](http://purl.obolibrary.org/obo/OMIM_202110), [Orphanet:90796](http://www.orpha.net/ORDO/Orphanet_90796), [Orphanet:2855](http://www.orpha.net/ORDO/Orphanet_2855), [OMIM:233300](http://purl.obolibrary.org/obo/OMIM_233300), [OMIM:208900](http://purl.obolibrary.org/obo/OMIM_208900), [Orphanet:436182](http://www.orpha.net/ORDO/Orphanet_436182), [Orphanet:90790](http://www.orpha.net/ORDO/Orphanet_90790), [Orphanet:126](http://www.orpha.net/ORDO/Orphanet_126), [OMIM:400045](http://purl.obolibrary.org/obo/OMIM_400045), [Orphanet:90793](http://www.orpha.net/ORDO/Orphanet_90793), 

**Class expressions from DL-Learner:**

- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) and [HP:0004322](http://purl.obolibrary.org/obo/HP_0004322) (Short stature) 65.62%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) 65.62%
- [HP:0000823](http://purl.obolibrary.org/obo/HP_0000823) (Delayed puberty) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0004322](http://purl.obolibrary.org/obo/HP_0004322) (Short stature) 65.62%
- [HP:0000823](http://purl.obolibrary.org/obo/HP_0000823) (Delayed puberty) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 65.62%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0004322](http://purl.obolibrary.org/obo/HP_0004322) (Short stature) 65.62%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 65.62%
- [HP:0000002](http://purl.obolibrary.org/obo/HP_0000002) (Abnormality of body height) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) 65.62%
- [HP:0000002](http://purl.obolibrary.org/obo/HP_0000002) (Abnormality of body height) and [HP:0000823](http://purl.obolibrary.org/obo/HP_0000823) (Delayed puberty) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) 65.62%
- [HP:0000002](http://purl.obolibrary.org/obo/HP_0000002) (Abnormality of body height) and [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) 65.62%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0004322](http://purl.obolibrary.org/obo/HP_0004322) (Short stature) and [HP:0004349](http://purl.obolibrary.org/obo/HP_0004349) (Reduced bone mineral density) 65.62%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0004322](http://purl.obolibrary.org/obo/HP_0004322) (Short stature) and [HP:0004348](http://purl.obolibrary.org/obo/HP_0004348) (Abnormality of bone mineral density) 65.62%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0004349](http://purl.obolibrary.org/obo/HP_0004349) (Reduced bone mineral density) 65.62%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0004348](http://purl.obolibrary.org/obo/HP_0004348) (Abnormality of bone mineral density) 65.62%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0000939](http://purl.obolibrary.org/obo/HP_0000939) (Osteoporosis) and [HP:0004322](http://purl.obolibrary.org/obo/HP_0004322) (Short stature) 65.62%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0000939](http://purl.obolibrary.org/obo/HP_0000939) (Osteoporosis) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 65.62%


